CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 253 filers reported holding CUBIST PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $216,352,000 | -47.1% | 2,149,550 | -65.1% | 0.06% | -49.6% |
Q3 2014 | $409,113,000 | +8.3% | 6,166,910 | +14.0% | 0.11% | +10.8% |
Q2 2014 | $377,848,000 | -6.0% | 5,411,728 | -1.5% | 0.10% | -8.9% |
Q1 2014 | $401,891,000 | -0.7% | 5,494,068 | -6.5% | 0.11% | -3.4% |
Q4 2013 | $404,602,000 | -2.8% | 5,874,869 | -10.3% | 0.12% | -10.8% |
Q3 2013 | $416,439,000 | +31.4% | 6,552,923 | -0.1% | 0.13% | +26.2% |
Q2 2013 | $316,857,000 | – | 6,560,198 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 756,821 | $36,547,000 | 4.31% |
SECTOR GAMMA AS | 289,442 | $13,977,000 | 4.08% |
HealthCor Management, L.P. | 1,200,000 | $57,948,000 | 3.50% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,500,000 | $72,435,000 | 3.41% |
Duquesne Family Office | 413,000 | $19,944,000 | 2.96% |
KING INVESTMENT ADVISORS INC/TX | 127,705 | $6,167,000 | 2.56% |
BNP PARIBAS FINANCIAL MARKETS | 17,275,000 | $3,026,410,000,000 | 2.14% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 572,762 | $27,658,000 | 1.84% |
Tekla Capital Management LLC | 265,972 | $12,846,000 | 1.75% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 695,000 | $33,562,000 | 1.58% |